Separation and Characterization of the Colloidal Phases Produced on Digestion of Common Formulation Lipids and Assessment of Their Impact on the Apparent Solubility of Selected Poorly Water-Soluble Drugs

Colloidal mixtures containing bile salts (BS), phosphatidylcholine (PC), and medium and long-chain monoglycerides and fatty acids were prepared as model systems to represent typical intestinal contents after digestion of formulation derived lipids under both low (5mM BS/1.25mM PC) and high (20mM BS/...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical sciences 2003-03, Vol.92 (3), p.634-648
Hauptverfasser: Kossena, Greg A., Boyd, Ben J., Porter, Christopher J.H., Charman, William N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 648
container_issue 3
container_start_page 634
container_title Journal of pharmaceutical sciences
container_volume 92
creator Kossena, Greg A.
Boyd, Ben J.
Porter, Christopher J.H.
Charman, William N.
description Colloidal mixtures containing bile salts (BS), phosphatidylcholine (PC), and medium and long-chain monoglycerides and fatty acids were prepared as model systems to represent typical intestinal contents after digestion of formulation derived lipids under both low (5mM BS/1.25mM PC) and high (20mM BS/5mM PC) BS and PC conditions. Size-exclusion chromatography of the colloidal species that formed in the medium-chain digests indicated the presence of vesicles, mixed micelles, and simple micelles, whereas the long-chain digests contained only vesicles and mixed micelles. In the long-chain digests the mixed micellar phase was the predominant drug solubilizing species for griseofulvin, danazol, and halofantrine, although for increasingly lipophilic drugs, the vesicular phase contributed an increasing proportion of the solubilization capacity. In contrast, the solubilization capacity of the vesicular phase was predominant in the medium-chain digests, and no clear trends were evident in the relationship between drug lipophilicity and proportional solubilization. These data highlight the need to consider the colloidal species that form in the small intestine during the digestion of common formulation lipids and the coincident enhancement in drug solubilization provided under these circumstances.
doi_str_mv 10.1002/jps.10329
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73038130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354916363080</els_id><sourcerecordid>73038130</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4339-9d237050f110abff1819804b5d9f30caaebbc169e3254824a054834455c76f7c3</originalsourceid><addsrcrecordid>eNp1ksuO0zAUhi0EYkphwQsgb0BiEcaO41yWVYcOMypQqUWztBznZOrBiYOdAOUVeSmcpsNsYOPjy3f-c-zfCL2k5B0lJD6_63yYsLh4hGaUxyRKCc0eo1k4iyPGk-IMPfP-jhCSEs6fojMa8zwLwwz93kInney1bbFsK7zch5Xqwelf06atcb8HvLTGWF1Jgzd76cHjjbPVoKDCgbnQt-Dv6aVtmjBbWdcMZtJY605X_qi_8CHZN9D2I7vbg3b4qulCyVForLToQkPj-daaodRG94cR3YKB0FeFN9Y6c8A3MjQZHRkD-MINt_45elJL4-HFKc7Rl9X73fJDtP58ebVcrCOVMFZERRWzjHBSU0pkWdc0p0VOkpJXRc2IkhLKUtG0ABbzJI8TSUJgScK5ytI6U2yO3ky6nbPfhnBz0WivwBjZgh28yBhhOQ3DHL2dQOWs9w5q0TndSHcQlIjRORGcE0fnAvvqJDqUDVQP5MmqALw-AdIraWonW6X9A5fwnOdFGrjzifuhDRz-X1Fcb7b3paMpQ_sefv7NkO6rSDOWcXHz6VJ8XMU5TVbXYhd4NvEQHvm7Bie80tCGz6Bd8EhUVv_jgn8AlwzTew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73038130</pqid></control><display><type>article</type><title>Separation and Characterization of the Colloidal Phases Produced on Digestion of Common Formulation Lipids and Assessment of Their Impact on the Apparent Solubility of Selected Poorly Water-Soluble Drugs</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Kossena, Greg A. ; Boyd, Ben J. ; Porter, Christopher J.H. ; Charman, William N.</creator><creatorcontrib>Kossena, Greg A. ; Boyd, Ben J. ; Porter, Christopher J.H. ; Charman, William N.</creatorcontrib><description>Colloidal mixtures containing bile salts (BS), phosphatidylcholine (PC), and medium and long-chain monoglycerides and fatty acids were prepared as model systems to represent typical intestinal contents after digestion of formulation derived lipids under both low (5mM BS/1.25mM PC) and high (20mM BS/5mM PC) BS and PC conditions. Size-exclusion chromatography of the colloidal species that formed in the medium-chain digests indicated the presence of vesicles, mixed micelles, and simple micelles, whereas the long-chain digests contained only vesicles and mixed micelles. In the long-chain digests the mixed micellar phase was the predominant drug solubilizing species for griseofulvin, danazol, and halofantrine, although for increasingly lipophilic drugs, the vesicular phase contributed an increasing proportion of the solubilization capacity. In contrast, the solubilization capacity of the vesicular phase was predominant in the medium-chain digests, and no clear trends were evident in the relationship between drug lipophilicity and proportional solubilization. These data highlight the need to consider the colloidal species that form in the small intestine during the digestion of common formulation lipids and the coincident enhancement in drug solubilization provided under these circumstances.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.10329</identifier><identifier>PMID: 12587125</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Biological and medical sciences ; Chemistry, Pharmaceutical ; Colloids - analysis ; Colloids - chemistry ; drug solubilization ; General pharmacology ; intermicellar concentration ; lipid-based formulations ; Lipids - analysis ; Lipids - chemistry ; Medical sciences ; Pharmaceutical Preparations - analysis ; Pharmaceutical Preparations - chemistry ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; poorly water soluble drugs ; size-exclusion chromatography ; Solubility ; Water - chemistry</subject><ispartof>Journal of pharmaceutical sciences, 2003-03, Vol.92 (3), p.634-648</ispartof><rights>2003 2003 Wiley-Liss, Inc.</rights><rights>Copyright © 2003 Wiley‐Liss, Inc.</rights><rights>2003 INIST-CNRS</rights><rights>Copyright 2003 Wiley-Liss, Inc. and the American Pharmaceutical Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4339-9d237050f110abff1819804b5d9f30caaebbc169e3254824a054834455c76f7c3</citedby><cites>FETCH-LOGICAL-c4339-9d237050f110abff1819804b5d9f30caaebbc169e3254824a054834455c76f7c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.10329$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.10329$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14585896$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12587125$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kossena, Greg A.</creatorcontrib><creatorcontrib>Boyd, Ben J.</creatorcontrib><creatorcontrib>Porter, Christopher J.H.</creatorcontrib><creatorcontrib>Charman, William N.</creatorcontrib><title>Separation and Characterization of the Colloidal Phases Produced on Digestion of Common Formulation Lipids and Assessment of Their Impact on the Apparent Solubility of Selected Poorly Water-Soluble Drugs</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>Colloidal mixtures containing bile salts (BS), phosphatidylcholine (PC), and medium and long-chain monoglycerides and fatty acids were prepared as model systems to represent typical intestinal contents after digestion of formulation derived lipids under both low (5mM BS/1.25mM PC) and high (20mM BS/5mM PC) BS and PC conditions. Size-exclusion chromatography of the colloidal species that formed in the medium-chain digests indicated the presence of vesicles, mixed micelles, and simple micelles, whereas the long-chain digests contained only vesicles and mixed micelles. In the long-chain digests the mixed micellar phase was the predominant drug solubilizing species for griseofulvin, danazol, and halofantrine, although for increasingly lipophilic drugs, the vesicular phase contributed an increasing proportion of the solubilization capacity. In contrast, the solubilization capacity of the vesicular phase was predominant in the medium-chain digests, and no clear trends were evident in the relationship between drug lipophilicity and proportional solubilization. These data highlight the need to consider the colloidal species that form in the small intestine during the digestion of common formulation lipids and the coincident enhancement in drug solubilization provided under these circumstances.</description><subject>Biological and medical sciences</subject><subject>Chemistry, Pharmaceutical</subject><subject>Colloids - analysis</subject><subject>Colloids - chemistry</subject><subject>drug solubilization</subject><subject>General pharmacology</subject><subject>intermicellar concentration</subject><subject>lipid-based formulations</subject><subject>Lipids - analysis</subject><subject>Lipids - chemistry</subject><subject>Medical sciences</subject><subject>Pharmaceutical Preparations - analysis</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>poorly water soluble drugs</subject><subject>size-exclusion chromatography</subject><subject>Solubility</subject><subject>Water - chemistry</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1ksuO0zAUhi0EYkphwQsgb0BiEcaO41yWVYcOMypQqUWztBznZOrBiYOdAOUVeSmcpsNsYOPjy3f-c-zfCL2k5B0lJD6_63yYsLh4hGaUxyRKCc0eo1k4iyPGk-IMPfP-jhCSEs6fojMa8zwLwwz93kInney1bbFsK7zch5Xqwelf06atcb8HvLTGWF1Jgzd76cHjjbPVoKDCgbnQt-Dv6aVtmjBbWdcMZtJY605X_qi_8CHZN9D2I7vbg3b4qulCyVForLToQkPj-daaodRG94cR3YKB0FeFN9Y6c8A3MjQZHRkD-MINt_45elJL4-HFKc7Rl9X73fJDtP58ebVcrCOVMFZERRWzjHBSU0pkWdc0p0VOkpJXRc2IkhLKUtG0ABbzJI8TSUJgScK5ytI6U2yO3ky6nbPfhnBz0WivwBjZgh28yBhhOQ3DHL2dQOWs9w5q0TndSHcQlIjRORGcE0fnAvvqJDqUDVQP5MmqALw-AdIraWonW6X9A5fwnOdFGrjzifuhDRz-X1Fcb7b3paMpQ_sefv7NkO6rSDOWcXHz6VJ8XMU5TVbXYhd4NvEQHvm7Bie80tCGz6Bd8EhUVv_jgn8AlwzTew</recordid><startdate>200303</startdate><enddate>200303</enddate><creator>Kossena, Greg A.</creator><creator>Boyd, Ben J.</creator><creator>Porter, Christopher J.H.</creator><creator>Charman, William N.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200303</creationdate><title>Separation and Characterization of the Colloidal Phases Produced on Digestion of Common Formulation Lipids and Assessment of Their Impact on the Apparent Solubility of Selected Poorly Water-Soluble Drugs</title><author>Kossena, Greg A. ; Boyd, Ben J. ; Porter, Christopher J.H. ; Charman, William N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4339-9d237050f110abff1819804b5d9f30caaebbc169e3254824a054834455c76f7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Biological and medical sciences</topic><topic>Chemistry, Pharmaceutical</topic><topic>Colloids - analysis</topic><topic>Colloids - chemistry</topic><topic>drug solubilization</topic><topic>General pharmacology</topic><topic>intermicellar concentration</topic><topic>lipid-based formulations</topic><topic>Lipids - analysis</topic><topic>Lipids - chemistry</topic><topic>Medical sciences</topic><topic>Pharmaceutical Preparations - analysis</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>poorly water soluble drugs</topic><topic>size-exclusion chromatography</topic><topic>Solubility</topic><topic>Water - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kossena, Greg A.</creatorcontrib><creatorcontrib>Boyd, Ben J.</creatorcontrib><creatorcontrib>Porter, Christopher J.H.</creatorcontrib><creatorcontrib>Charman, William N.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kossena, Greg A.</au><au>Boyd, Ben J.</au><au>Porter, Christopher J.H.</au><au>Charman, William N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Separation and Characterization of the Colloidal Phases Produced on Digestion of Common Formulation Lipids and Assessment of Their Impact on the Apparent Solubility of Selected Poorly Water-Soluble Drugs</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>2003-03</date><risdate>2003</risdate><volume>92</volume><issue>3</issue><spage>634</spage><epage>648</epage><pages>634-648</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>Colloidal mixtures containing bile salts (BS), phosphatidylcholine (PC), and medium and long-chain monoglycerides and fatty acids were prepared as model systems to represent typical intestinal contents after digestion of formulation derived lipids under both low (5mM BS/1.25mM PC) and high (20mM BS/5mM PC) BS and PC conditions. Size-exclusion chromatography of the colloidal species that formed in the medium-chain digests indicated the presence of vesicles, mixed micelles, and simple micelles, whereas the long-chain digests contained only vesicles and mixed micelles. In the long-chain digests the mixed micellar phase was the predominant drug solubilizing species for griseofulvin, danazol, and halofantrine, although for increasingly lipophilic drugs, the vesicular phase contributed an increasing proportion of the solubilization capacity. In contrast, the solubilization capacity of the vesicular phase was predominant in the medium-chain digests, and no clear trends were evident in the relationship between drug lipophilicity and proportional solubilization. These data highlight the need to consider the colloidal species that form in the small intestine during the digestion of common formulation lipids and the coincident enhancement in drug solubilization provided under these circumstances.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><pmid>12587125</pmid><doi>10.1002/jps.10329</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 2003-03, Vol.92 (3), p.634-648
issn 0022-3549
1520-6017
language eng
recordid cdi_proquest_miscellaneous_73038130
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Biological and medical sciences
Chemistry, Pharmaceutical
Colloids - analysis
Colloids - chemistry
drug solubilization
General pharmacology
intermicellar concentration
lipid-based formulations
Lipids - analysis
Lipids - chemistry
Medical sciences
Pharmaceutical Preparations - analysis
Pharmaceutical Preparations - chemistry
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
poorly water soluble drugs
size-exclusion chromatography
Solubility
Water - chemistry
title Separation and Characterization of the Colloidal Phases Produced on Digestion of Common Formulation Lipids and Assessment of Their Impact on the Apparent Solubility of Selected Poorly Water-Soluble Drugs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A58%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Separation%20and%20Characterization%20of%20the%20Colloidal%20Phases%20Produced%20on%20Digestion%20of%20Common%20Formulation%20Lipids%20and%20Assessment%20of%20Their%20Impact%20on%20the%20Apparent%20Solubility%20of%20Selected%20Poorly%20Water-Soluble%20Drugs&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Kossena,%20Greg%20A.&rft.date=2003-03&rft.volume=92&rft.issue=3&rft.spage=634&rft.epage=648&rft.pages=634-648&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.10329&rft_dat=%3Cproquest_cross%3E73038130%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73038130&rft_id=info:pmid/12587125&rft_els_id=S0022354916363080&rfr_iscdi=true